OUTSMARTING 2023 AWARD PROGRAM

MIB Agents is now accepting applications for our 2023 OutSmarting Osteosarcoma grant cycle.
‍
The OutSmarting Osteosarcoma Research Award
$100,000 grant over one year to any investigator with a compelling study that will Make It Better for osteosarcoma patients.

The OutSmarting Osteosarcoma Young Investigator (YI) Research Award
$50,000 grant over one year to any young investigator with a compelling study that will Make It Better for osteosarcoma patients.

Awards may be sponsored by one MIB Agents Family Fund or individual donor, which is co-branded in honor of the Family Fund. Multiple grants will be awarded in 2023, and the number of grants by award type will be determined based on budget and program goals during programmatic review.

ABOUT THE OUTSMARTING OSTEOSARCOMA GRANT PROGRAM

$950,000 awarded to date
The OutSmarting Osteosarcoma Research Grant is an annual award begun in 2017. Since then, MIB Agents has supported eleven investigators and awarded $950,000 to support osteosarcoma research.

Family Funds Supporting Science
Collaboration among the scientific and patient community is a key hallmark of MIB Agents. MIB Agents OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise funds in honor of an OsteoWarrior or OsteoAngel. Their dedication to Making It Better and fostering collaboration and education in the scientific community makes every MIB Agents award incredibly meaningful.
‍
Our collaborative and robust review process
The two tier-review process results in a robust and collaborative review process that uniquely
incorporates patient and family perspective.

Please email christina@mibagents.org with any questions.